When it comes to killing cancer cells, two drugs are often better than one. Some drug combinations offer a one-two punch that kills cells more effectively, requires lower doses of each drug, and can help to prevent drug resistance.
Jul 11, 2019
0
70
Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma, the U.S. Food and Drug Administration announced last week.
Jul 10, 2019
0
0
New findings show how a genetically aberrant, fused protein promotes a rare form of liver cancer in adolescents and young adults. The researchers also saw that a certain mix of drugs could target the fused protein and the ...
Jul 9, 2019
0
0
Tuberculosis is a potentially deadly though curable disease. Each year about 10 million people develop active cases, and 1.6 million people die. In addition, about 1.7 billion people around the world are infected with TB ...
May 14, 2019
0
74
(HealthDay)—The combination of pembrolizumab and axitinib has been approved as a first-line treatment in advanced renal cell carcinoma (RCC), the U.S. Food and Drug Administration announced Friday.
Apr 23, 2019
0
2
Treating breast tumors with two cancer drugs simultaneously may prevent endocrine resistance by attacking the disease along two separate gene pathways, scientists at the University of Illinois found in a new study.
Apr 23, 2019
0
6
Patients who stopped taking aspirin three months after receiving a stent to open the heart's arteries but continued taking a P2Y12 inhibitor—clopidogrel, prasugrel or ticagrelor—did not experience higher rates of death ...
Mar 18, 2019
0
1
A diet containing compounds found in green tea and carrots reversed Alzheimer's-like symptoms in mice genetically programmed to develop the disease, USC researchers say.
Mar 6, 2019
2
1212
Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren't as effective as they could be. Oncologists haven't had the right tools to predict drug interactions, other than in costly ...
Feb 21, 2019
0
25
A combination of two drugs—one of them an immunotherapy agent—could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting ...
Feb 17, 2019
0
62
